CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-08 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +14,683 | $84.98 | $1.2M | 455,482 |
| 2024-07-08 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −14,683 | $192.97 | $2.8M | 440,799 |
| 2024-07-08 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −14,683 | 58,732 | ||
| 2024-07-08 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $194.35 | $194K | 90,056 |
| 2024-06-10 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $209.81 | $210K | 91,056 |
| 2024-06-07 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +14,683 | $84.98 | $1.2M | 455,482 |
| 2024-06-07 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −14,683 | $211.66 | $3.1M | 440,799 |
| 2024-06-07 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −14,683 | 73,415 | ||
| 2024-06-04 | Rider Michael J Global General Counsel | Shares withheld for taxes | −267.24 | $206.33 | $55K | 6,444 |
| 2024-05-24 | Burt Carol Director | Gift | −47 | 14,892 | ||
| 2024-05-15 | De Witte Jan Director | Sale 10b5-1 | −360 | $218.29 | $79K | 7,519 |
| 2024-05-15 | FARRELL PETER C Director | Gift | −68,200 | 89,204 | ||
| 2024-05-15 | De Witte Jan Director | Sale | −360 | $218.29 | $79K | 7,519 |
| 2024-05-08 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +12,000 | $101.64 | $1.2M | 105,056 |
| 2024-05-08 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −13,000 | $211.37 | $2.7M | 92,056 |
| 2024-05-08 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −12,000 | 10,883 | ||
| 2024-05-07 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +1,176 | $84.98 | $100K | 441,928 |
| 2024-05-07 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +13,507 | $84.98 | $1.1M | 455,435 |
| 2024-05-07 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −14,683 | $216.50 | $3.2M | 440,752 |
| 2024-05-07 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −1,176 | 101,605 |
Page 15 of 19 · 361 trades